Cannabis treatment programs are increasingly being implemented in various parts of the world to supply access to marijuana-derived treatments for patients who have severe medical conditions. These programs are designed to ensure that only genuine cannabis use is authorized, and that patients have safe access to a form of treatment that might otherwise be strictly regulated or disallowed in their region.

The legality surrounding medical cannabis differ significantly from country to country and often within countries at different levels of governance, with laws pertaining to production changing nearly as often. Even the countries that allow access to medical cannabis have a complex governance and regulatory process prior to its use.

Historically, the loci of medical cannabis decision-making was primarily left to individual state governments. Each federal state has its unique set of rules guiding the use of cannabis for medical purposes. Individual state systems offer distinct paths to patients for obtaining medical cannabis and access to the substance.

A key guiding principle guiding the regulation of medical cannabis loci is the 'double-blind' doctor patient relationship facilitating clinicians where to get weed in paris prescribe marijuana based on the health needs of the patient, risk-free of being arrested or persecuted for their illegal suggestion. To prescribe marijuana a healthcare provider must pinpoint the condition the patient will be using the medication for and provide a legitimate reason for its use.

For a patient to reap the benefits of medical cannabis a clinician should also provide the proper dosage for the prescribed use and instruct on how to properly administer the substance so that the patient gets the right measurements based on the recommendation. Following a formal doctor-patient consultation and written recommendation for therapeutic use of cannabis, the patient would need to apply for a state-issued Medical Cannabis Registry Card that formalizes the permission.

In spite of, these state-specific programs have flaws such as unsustainable production and distribution infrastructures that can make medical cannabis hard to access, over-regulated guidelines that restrict usage, and an ongoing culture of stigma towards medical cannabis users. These actions have had effects such as driving patients to the dark web and making individuals self-diagnose medicinal uses which destabilizes the quality of medical treatment they can utilize in conjunction with cannabis.